Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment in Patients with Relapsed/Refractory Mantle Cell Lymphoma

被引：0
|
作者：
Patel, Krish [1 ]
Teschemaker, Anna [2 ]
Tian, Hongping [3 ]
Pyrih, Nick [3 ]
Kolvenbag, Geert [2 ]
Patel, Shweta [2 ]
Wahlstrom, Svea K. [4 ]
Cui, Lianzhou [3 ]
机构：
[1] Swedish Canc Inst, Seattle, WA USA
[2] AstraZeneca, Gaithersburg, MD USA
[3] Cobbs Creek Hlth Care, Newtown Sq, PA USA
[4] AstraZeneca, Wilmington, DE USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-194523
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7745 / 7745
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD TREATMENT OUTCOMES AMONG RELAPSED/REFRACTORY PATIENTS WITH MANTLE CELL LYMPHOMA TREATED WITH IBRUTINIB OR ACALABRUTINIB
    Crawford, S.
    Lafeuille, M. H.
    Emond, B.
    Harb, D.
    Voladarsky, R.
    Chen, N.
    Karve, S.
    VALUE IN HEALTH, 2023, 26 (06) : S403 - S403
  • [2] Real-World Outcomes for Patients Treated with Ibrutinib for Relapsed/Refractory Mantle Cell Lymphoma in Denmark
    Trab, Trine
    Chanchiri, Iman
    Al-Mashhadi, Ahmed
    Berggreen, Emma
    Rasch, Stine
    Johansen, Mette
    Husby, Simon
    Clausen, Michael Roost
    Larsen, Thomas Stauffer
    Desseau-Arp, Andriette C.
    Christensen, Jacob Haaber
    Pedersen, Robert Schou
    Frederiksen, Mikael
    Brown, Peter de Nully
    El-Galaly, Tarec Christoffer
    Gronbaek, Kirsten
    BLOOD, 2024, 144 : 6325 - 6326
  • [3] Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real-world experience
    Jeon, Young-Woo
    Yoon, Seugyun
    Min, Gi June
    Park, Sung-Soo
    Park, Silvia
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Lee, Seok
    Min, Chang-Ki
    Lee, Jong Wook
    Cho, Seok-Goo
    CANCER MEDICINE, 2019, 8 (16): : 6860 - 6870
  • [4] Real-World Evidence of Brexucabtagene Autoleucel for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
    Iacoboni, Gloria
    Rejeski, Kai
    Camacho, Lina
    Chiappella, Annalisa
    Guadagnuolo, Serafina
    Lopez Corral, Lucia
    Bastos-Oreiro, Mariana
    Delgado Serrano, Javier
    Schmidt, Christian
    Carpio, Cecilia
    Luis Reguera, Juan
    Kwon, Mi
    Martin Garcia-Sancho, Alejandro
    Luigi Zinzani, Pier
    Corradini, Paolo
    Subklewe, Marion
    Barba, Pere
    BLOOD, 2021, 138
  • [5] Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
    Iacoboni, Gloria
    Rejeski, Kai
    Villacampa, Guillermo
    van Doesum, Jaap A.
    Chiappella, Annalisa
    Bonifazi, Francesca
    Lopez-Corral, Lucia
    van Aalderen, Michiel
    Kwon, Mi
    Martinez-Cibrian, Nuria
    Bramanti, Stefania
    Luis Reguera-Ortega, Juan
    Camacho-Arteaga, Lina
    Schmidt, Christian
    Marin-Niebla, Ana
    Jose Kersten, Marie
    Martin Garcia-Sancho, Alejandro
    Zinzani, Pier Luigi
    Corradini, Paolo
    van Meerten, Tom
    Subklewe, Marion
    Barba, Pere
    BLOOD ADVANCES, 2022, 6 (12) : 3606 - 3610
  • [6] Real-world effectiveness and safety of ibrutinib in relapsed/refractory mantle cell lymphoma in Japan: post-marketing surveillance
    Maruyama, Dai
    Omi, Ai
    Nomura, Fumi
    Touma, Tokiko
    Noguchi, Yukiko
    Takebe, Kyoko
    Izutsu, Koji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (02) : 146 - 155
  • [7] Real-world effectiveness and safety of ibrutinib in relapsed/refractory mantle cell lymphoma in Japan: post-marketing surveillance
    Dai Maruyama
    Ai Omi
    Fumi Nomura
    Tokiko Touma
    Yukiko Noguchi
    Kyoko Takebe
    Koji Izutsu
    International Journal of Hematology, 2024, 119 : 146 - 155
  • [8] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma
    Fernandez, Laura Lorente
    Dominguez, Samuel Romero
    Mari, Asuncion Albert
    Benito, Esperanza Nunez
    Briz, Eduardo Lopez
    Andres, Jose Luis Poveda
    FARMACIA HOSPITALARIA, 2025, 49 (01) : T17 - T23
  • [9] Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real-World Outcomes in the United Kingdom
    O'Reilly, Maeve A.
    Sanderson, Robin
    Wilson, William
    Burns, David
    Besley, Caroline
    Creasey, Thomas
    Uttenthal, Ben
    Elliot, Johnathon
    Roddie, Claire
    Kuhnl, Andrea
    Paneesha, Shankara
    Seymour, Frances
    Iyengar, Sunil
    Rubio, Lourdes
    Wilson, Matthew
    Boyle, Stephen
    Cheok, Kathleen Pl
    Collins, Graham P.
    Johnson, Rod
    McMillan, Andrew K.
    BLOOD, 2022, 140 : 7519 - 7521
  • [10] Real-World Evidence of Relapsed/Refractory Mantle Cell Lymphoma Patients and Treatments: A Systematic Review
    Sancho, Juan-Manuel
    Sorigue, Marc
    Rubio-Azpeitia, Eva
    JOURNAL OF BLOOD MEDICINE, 2024, 15 : 239 - 254
12345